Olmesartan medoxomil self-microemulsifying drug delivery system reverses apoptosis and improves cell adhesion in trinitrobenzene sulfonic acid-induced colitis in rats
In conclusion, OMS could be a potential additive treatment for Crohn's disease colitis.PMID:35766160 | DOI:10.1080/10717544.2022.2086939
Source: Drug Delivery - Category: Drugs & Pharmacology Authors: Hussam Murad Osama Ahmed Thamer Alqurashi Mostafa Hussien Source Type: research
More News: Antidoxidants | Benicar | Crohn's Disease | Drugs & Pharmacology | Inflammatory Bowel Disease | Lymphoma | Study